Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer
Clin Transl Med. 2025 Dec;15(12):e70543. doi: 10.1002/ctm2.70543.ABSTRACTBACKGROUND:…
Microbiome as a predictive biomarker in locally advanced rectal cancer
Microbiome Res Rep. 2025 Mar 24;4(2):18. doi: 10.20517/mrr.2024.85.…
Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies
Cell Death Discov. 2025 Mar 7;11(1):91. doi: 10.1038/s41420-025-02379-y.ABSTRACTA…
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib
Cancers (Basel). 2025 Jan 23;17(3):375. doi: 10.3390/cancers17030375.ABSTRACTWe…
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy
Int J Mol Sci. 2024 Nov 14;25(22):12241. doi: 10.3390/ijms252212241.ABSTRACTTriple-negative…
Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets
Int Rev Cell Mol Biol. 2024;388:162-205. doi: 10.1016/bs.ircmb.2024.03.008.…
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment
Biomed Pharmacother. 2024 Jun 7;176:116857. doi: 10.1016/j.biopha.2024.116857.…
The European Network for Sinonasal Cancer Research (EUSICA) – A pan-European initiative targeting a group of orphan tumours
Eur J Cancer. 2024 May;202:113939. doi: 10.1016/j.ejca.2024.113939.…
Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?
Pharmacol Res. 2023 Oct;196:106924. doi: 10.1016/j.phrs.2023.106924.…
EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report
Oral Oncol. 2023 Nov;146:106543. doi: 10.1016/j.oraloncology.2023.106543.…
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
Int J Mol Sci. 2022 Nov 14;23(22):14058. doi: 10.3390/ijms232214058.ABSTRACTColorectal…
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
Breast. 2022 Apr;62:1-9. doi: 10.1016/j.breast.2022.01.007. Epub…
